tiprankstipranks
Passage Bio (PASG)
NASDAQ:PASG
US Market
Holding PASG?
Track your performance easily

Passage Bio (PASG) Financial Statements

446 Followers

Passage Bio Financial Overview

Passage Bio's market cap is currently ―. The company's EPS TTM is $-1.174; its P/E ratio is -0.43; Passage Bio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 332.00K$ 243.00K---
Gross Profit$ 332.00K$ 243.00K---
EBIT$ -19.34M$ -15.99M$ -16.75M$ -18.45M$ -23.28M
EBITDA$ -18.96M$ -15.49M$ -16.39M$ -17.64M$ -22.32M
Net Income Common Stockholders$ -19.34M$ -15.98M$ -16.71M$ -16.76M$ -27.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 84.83M$ 91.77M$ 104.53M$ 114.29M$ 132.78M
Total Assets$ 111.75M$ 125.39M$ 140.53M$ 150.54M$ 169.26M
Total Debt$ 25.82M$ 26.15M$ 26.48M$ 26.29M$ 26.52M
Net Debt$ -59.01M$ -65.62M$ -78.05M$ -88.00M$ -106.26M
Total Liabilities$ 39.04M$ 34.84M$ 35.65M$ 39.26M$ 42.98M
Stockholders Equity$ 72.72M$ 90.53M$ 104.88M$ 111.28M$ 126.28M
Cash Flow-
Free Cash Flow$ -7.47M$ -13.14M$ -18.93M$ -19.53M$ -19.17M
Operating Cash Flow$ -7.45M$ -13.14M$ -18.93M$ -19.52M$ -19.16M
Investing Cash Flow$ 14.97M$ 1.05M$ 25.25M$ 7.60M$ 22.45M
Financing Cash Flow-$ 85.00K$ 8.74M$ 46.00K-
Currency in USD

Passage Bio Earnings and Revenue History

Passage Bio Debt to Assets

Passage Bio Cash Flow

Passage Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis